Hyaluronic acid-tailored prodrug nanoplatforms for efficiently overcoming colorectal cancer chemoresistance and recurrence by synergistic inhibition of cancer cell stemness
Abstract A subset of residual colorectal cancer (CRC) cells with stemness features exhibits a transient adaptive resistance after chemotherapy, limiting durable therapeutic benefits and even accelerating tumor recurrence. To tackle this problem, we have developed a targeted polymer prodrug nanoplatf...
Saved in:
| Main Authors: | Xirui Duan, Hailong Tian, Peilan Peng, Ping Zhou, Ning Ding, Guowen Liu, Gary T. Bentley, Canhua Huang, Jun Yang, Ke Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-025-03484-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Trends in Clinical Trials of Prodrugs
by: Diogo Boreski, et al.
Published: (2025-02-01) -
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
by: Jinzhe Liang, et al.
Published: (2024-09-01) -
Prodrug-based bispecific antibodies for cancer therapy: advances and future directions
by: Zhijuan Ai, et al.
Published: (2025-01-01) -
Preparation of Glutathione-Responsive Paclitaxel Prodrug Based on Endogenous Molecule of L-Glutathione Oxidized for Cancer Therapy
by: Xiao Duan, et al.
Published: (2024-09-01) -
Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect
by: Chengcheng Feng, et al.
Published: (2024-12-01)